How Many Kids Have ADHD? U.S. Prevalence and Trends

About one in nine U.S. children has received an ADHD diagnosis at some point, which translates to roughly 7.1 million kids. The most recent national estimate puts the ever-diagnosed rate at 11.4%, with about 10.5% (6.5 million) considered to have current ADHD.¹ Those numbers reflect decades of rising diagnosis rates, wide geographic gaps across states, and persistent disparities by race, sex, and income that make the national average only part of the story.

How the Numbers Have Changed Over Two Decades

ADHD diagnosis rates in the U.S. climbed steadily from the late 1990s through the mid-2010s. Over a 20-year window ending in 2016, the estimated prevalence among children and adolescents went from about 6% to roughly 10%, with the increase showing up across every subgroup researchers looked at, including all ages, sexes, racial and ethnic groups, income levels, and geographic regions.² That near-doubling fueled intense debate about whether more children actually have ADHD or whether changes in awareness and diagnostic practice were doing the heavy lifting.

Since around 2017, the national rate appears to have plateaued. Survey data covering 2017 through 2022 show the ever-diagnosed prevalence hovering between about 10% and 10.5% in each two-year cycle, without a clear upward or downward trend.³ That leveling off is worth noting because it came even as public awareness of ADHD continued to grow and telehealth made evaluations easier to access. The rate is not obviously accelerating anymore at the national level, though specific populations and regions tell a more complicated story.

One often-overlooked driver of the long upward trend is the diagnostic manual itself. When the American Psychiatric Association updated its criteria from DSM-IV to DSM-5 in 2013, the changes were expected to increase the number of young adults who qualify for a diagnosis by roughly 27%.⁴ Those revisions raised the age-of-onset cutoff and reduced the symptom count needed in adults, effectively widening the net. When the definition of a condition changes, prevalence shifts even if the underlying population stays the same.

Boys, Girls, and the Diagnosis Gap

ADHD is diagnosed far more often in boys than girls, roughly two to three times as frequently in most surveys. But the gap increasingly looks like it reflects how ADHD shows up rather than how often it occurs. Girls with ADHD tend to present with higher levels of self-reported anxiety, while boys more commonly display rule-breaking behavior that parents and teachers notice quickly.⁵ A child who is visibly disruptive in a classroom gets flagged earlier than one who is quietly struggling to focus, and that pattern falls along gender lines more often than not.

Research on how parents rate their children’s symptoms adds another layer. When structured clinical interviews are compared with standard parent questionnaires, parents tend to under-rate hyperactive and impulsive symptoms in girls and over-rate those same symptoms in boys.⁶ Girls who do meet diagnostic criteria also receive lower parent-rated impact scores for overall distress and impairment compared with equivalent boys. The practical result is that a girl with ADHD may look less impaired on paper even when the clinical picture is comparable. This rating bias likely contributes to later and fewer diagnoses in girls, which in turn depresses the apparent prevalence among female children.

Racial and Ethnic Disparities in Diagnosis

White children in the U.S. are diagnosed with ADHD at significantly higher rates than children of other racial and ethnic backgrounds. In a large national birth cohort, Asian children were about half as likely to receive an ADHD diagnosis as White children, while Black and Hispanic children were roughly 17% to 23% less likely after adjusting for sex, region, and household income.⁷ White children were also more likely to receive some kind of treatment once diagnosed, and Asian children had the highest odds of receiving no treatment at all.

These gaps do not mean ADHD is less common in non-White children. Researchers have pointed to a mix of factors: differences in access to specialists, cultural attitudes toward behavioral diagnoses, language barriers during evaluation, and provider bias in recognizing symptoms. The disparity carries real consequences. A child who has ADHD but never gets evaluated misses out on school accommodations, behavioral strategies, and, when appropriate, medication, all of which have good evidence behind them. Treatment data from the Adolescent Brain Cognitive Development Study reinforce the pattern: among children with parent-reported ADHD, White children were more likely to be receiving medication than Black children.⁸

Massive State-by-State Differences

The national average of around 10% obscures enormous variation across the country. State-level estimates of ever-diagnosed ADHD in children range from about 6% at the low end to over 16% at the high end.⁹ States like California, Hawaii, Nevada, and New York sit well below the national figure, while a cluster of Southern states, including Louisiana, Kentucky, Arkansas, Alabama, and West Virginia, sit well above it. Seven states had rates significantly lower than the rest of the country, and 15 had rates significantly higher.

The regional divide is striking. Southern states consistently post the highest average diagnosis and medication rates, while Western states post the lowest.¹⁰ When researchers drill down to the county level, the pattern intensifies: more than half of counties in the West South Central and East South Central divisions have childhood ADHD rates of 16% or higher, compared with about 2% of counties in the Mountain division.¹¹

Why does the South diagnose ADHD at nearly triple the rate of parts of the West? The answer involves provider density, local clinical culture, how aggressively schools refer children for evaluation, socioeconomic stress, and access to mental health services. No single variable explains the gap cleanly, and the variation is a reminder that an ADHD prevalence number reflects the diagnostic ecosystem as much as the underlying biology.

The Overdiagnosis Question

Whether ADHD is overdiagnosed is one of the most contested questions in child psychiatry. A systematic scoping review covering 334 studies found what it called “convincing evidence” that ADHD is overdiagnosed in children and adolescents, particularly among those with milder symptoms where the harms of a label may outweigh the benefits.¹² A separate critical review pointed to several “artifactual factors” that may inflate rates, including how the diagnostic criteria are formulated, variable clinical practices, and a cultural focus on academic performance that is especially pronounced in North America.¹³

One of the more compelling pieces of evidence for overdiagnosis comes from birth-date studies. In Finland, children born in the last few months of the school year, making them the youngest in their class, had a significantly higher incidence of ADHD diagnosis than children born earlier in the year. The effect held for both boys and girls.¹⁴ Younger children in a class are developmentally behind their older peers by several months, a gap that can look like inattention or hyperactivity to a teacher comparing a child to classmates, not to an age-adjusted standard. Similar relative-age effects have been found in studies across multiple countries.

At the same time, many clinicians and researchers argue that underdiagnosis is the bigger problem, especially among girls, minority children, and those in low-income families who face barriers to evaluation. Both things can be true simultaneously: some children are getting diagnosed who probably should not be, while others who clearly meet the criteria are being missed entirely. The national prevalence number sits at the intersection of both errors.

Conditions That Travel With ADHD

Most children with ADHD also meet criteria for at least one other psychiatric condition. A large meta-analysis covering nearly 40,000 children and adolescents with ADHD found that the most common co-occurring disorders were:

Oppositional defiant disorder: about 35% of children with ADHD
Behavior disorders broadly: about 31%
Anxiety disorders: about 18%
Specific phobias: about 11%
Enuresis (bedwetting): about 11%
Conduct disorder: about 11%

Every individual disorder examined had a higher prevalence among children with ADHD than in the general population.¹⁵ This matters practically because a child who receives an ADHD diagnosis but has unrecognized anxiety or oppositional behavior may not respond well to standard ADHD treatment alone. It also complicates the diagnostic picture: anxiety can mimic inattention, and oppositional behavior can mimic hyperactivity, making it harder to tease apart what is driving the problems parents and teachers see.

Did the Pandemic Change ADHD Rates?

The COVID-19 pandemic disrupted virtually every aspect of children’s lives, and ADHD was no exception, though the nature of the impact depends on what you measure. A meta-analysis of studies comparing ADHD symptoms before and during the pandemic found a small but statistically meaningful increase in symptoms reported by children and their caregivers.¹⁶ Children lost structure, routines, and in-person social environments, and for kids with existing attention difficulties, that loss was particularly destabilizing.

Whether the pandemic drove an actual increase in formal diagnoses is more debatable. A 20-year cohort study concluded that the pandemic had no clear influence on ADHD diagnosis or treatment rates once the long-term upward trend was properly accounted for. The researchers warned that using a narrow pre-pandemic window for comparison can create the false impression that COVID-19 caused a spike.¹⁷ In Finland, however, new ADHD diagnoses doubled between the 2019–2020 and 2021–2022 periods, and roughly 18% of all new diagnoses during the pandemic years were estimated to be above what the existing upward trend would have predicted.¹⁸ The Finnish data suggest the pandemic may have accelerated diagnosis in a healthcare system structured differently from the U.S., so the effect is not necessarily generalizable.

How Many Kids With ADHD Actually Get Treatment?

A diagnosis does not guarantee treatment. In one study of over 1,200 children aged 9 to 10 with parent-reported ADHD, only about 13% were currently receiving ADHD medication, and roughly a quarter had ever received outpatient mental health care.⁸ Boys were more than twice as likely as girls to be on medication, and White children were more likely to be medicated than Black children. Children whose parents had less than a high school education had higher medication rates than those whose parents held a bachelor’s degree or higher, a somewhat counterintuitive finding that may reflect differences in access to non-medication treatments like behavioral therapy.

The gap between diagnosis and treatment is wide enough to raise concerns on its own. For children with moderate to severe ADHD, evidence-based treatment, whether behavioral, pharmacological, or both, improves academic functioning, peer relationships, and family stress. The fact that three-quarters of diagnosed children in one cohort had never seen a mental health provider suggests that for many families, getting the diagnosis is only the first barrier.

The Financial Weight of ADHD

ADHD carries substantial costs for families and the broader economy. One U.S. estimate put total annual societal excess costs at about $19 billion for children and nearly $14 billion for adolescents, amounting to roughly $6,800 per child and $8,300 per adolescent per year. Healthcare costs made up about a quarter to a third of that total, with caregiving costs and education-related expenses accounting for much of the rest.¹⁹

A systematic review and meta-analysis looking across multiple countries confirmed that direct medical costs are substantially higher for children with ADHD. The overall weighted average was about $5,300 per year in direct medical costs for a child with ADHD, compared with roughly $1,200 for a child without the diagnosis.²⁰ These figures reflect office visits, medication, therapy, and emergency care. What they do not capture well are the indirect costs to parents, including lost work hours, reduced career advancement, and the emotional toll of navigating school systems and insurance.

Is ADHD a Uniquely American Problem?

The perception that ADHD is an American invention or an artifact of American overdiagnosis does not hold up. A review of international studies found that prevalence rates in many countries are in the same range as in the U.S. when researchers use the same diagnostic criteria.²¹ What varies across countries is not the underlying rate of ADHD-like symptoms but how often those symptoms get formally diagnosed and treated. Countries with robust child psychiatry infrastructure and cultural acceptance of behavioral diagnoses tend to have higher diagnosed prevalence, while those without it tend to have lower numbers on paper but not necessarily fewer affected children.

That said, the U.S. does stand out in one respect. An analysis of global burden data from 1990 to 2019 across 204 countries found that the largest increase in ADHD incidence, prevalence, and overall burden occurred in the United States.²² Whether that reflects a genuine rise in ADHD or simply the world’s most aggressive diagnostic apparatus catching more cases is a question that the data alone cannot answer. The honest position is that it is probably both, in proportions that no one has confidently quantified.

Screening in Primary Care and Its Limitations

You might expect that universal screening at pediatric check-ups would be the obvious way to close diagnostic gaps, especially for girls and minority children who are currently underserved. In practice, implementation has been harder than it sounds. A pilot program that introduced ADHD screening in urban pediatric primary care found that screening completion rates were low, under 20% during the first six months. The barriers were not just logistical. Parents expressed hesitation about the screening itself, particularly around discussing mental health and medication, and families from marginalized communities had additional concerns about stigma and trust.²³

Telehealth has emerged as a potential supplement. Remote platforms can collect behavioral histories and symptom checklists before an in-person evaluation, potentially reducing wait times between when a parent first notices a problem and when the child sees a specialist. Early research suggests these tools can provide useful automated screening, though they are not a replacement for a full clinical evaluation.²⁴ The concern is that easier access to quick evaluations could widen the same overdiagnosis problem that already exists for children with mild symptoms, while still failing to reach the underdiagnosed populations who need the most help. Expanding access and improving accuracy are not the same goal, and solving one can inadvertently worsen the other.